Web Metrics and Site Analytics by WebSTAT

Diabetic Neuropathy Relief: Do Creams and Tablets Really Work?

Home » Diabetic Neuropathy Relief: Do Creams and Tablets Really Work?

Diabetic Neuropathy Relief: Do Creams and Tablets Really Work?

Written by: Michael Lee | Consumer Research, Brighton Savoy

An evidence-based, consumer-friendly guide to diabetic neuropathy, creams, tablets and supplements marketed for relief, and what current research actually supports.

Quick Answer: Do Diabetic Neuropathy Creams and Tablets Work?

Some treatments can help reduce symptoms, but no cream or supplement has been proven to reverse established diabetic nerve damage.

Topical capsaicin can reduce neuropathic pain for some people. Prescription medicines can also help manage painful diabetic neuropathy. Alpha-lipoic acid is one of the better-researched supplements and may reduce symptoms such as burning, tingling and numbness in some people, particularly around a 600mg daily dose.

However, symptom improvement is not the same as regenerating damaged nerves.

The 2026 American Diabetes Association Standards of Care state that specific treatment capable of reversing the underlying nerve damage of diabetic neuropathy is currently not available.

The most important long-term approach remains appropriate glucose management together with weight, blood pressure and lipid management, regular foot assessment and professional medical care.

Introduction: Why Neuropathy Products Are Everywhere

If you or someone close to you lives with diabetes, chances are you have come across creams, tablets, sprays or supplements claiming to relieve diabetic neuropathy.

Some promise less pain or burning.

Others make much stronger claims about improving circulation, restoring nerve health or even repairing damaged nerves.

The problem is that consumers are rarely told where reasonable symptom-relief claims end and unsupported nerve-regeneration claims begin.

This guide looks at:

  • what diabetic neuropathy actually is;
  • why it develops;
  • the symptoms people may experience;
  • what topical creams and gels can realistically do;
  • the evidence behind tablets and supplements;
  • alpha-lipoic acid and the 600mg dose;
  • prescription treatments for painful neuropathy;
  • consumer warning signs; and
  • what current clinical guidance says matters most.

The aim is not to sell you a neuropathy product.

It is to help you distinguish between symptom management, disease progression and claims of nerve repair.

What Is Diabetic Neuropathy?

Diabetic neuropathy refers to nerve disorders associated with diabetes.

The most common form is diabetic peripheral neuropathy, often called DPN, which commonly affects the feet and lower legs before potentially involving the hands.

The 2026 American Diabetes Association Standards of Care emphasise two particularly important points:

  • diabetic neuropathy is a diagnosis of exclusion, because people with diabetes can also develop neuropathy from other causes; and
  • up to 50% of diabetic peripheral neuropathy cases may be asymptomatic.

That means someone can have clinically important nerve damage without experiencing obvious pain, burning or tingling.

This is one reason regular foot and neurological assessment matters even when symptoms appear mild or absent.

Read the American Diabetes Association Standards of Care in Diabetes 2026.

The Most Common Type: Peripheral Neuropathy

Distal symmetric peripheral neuropathy generally affects the longest nerves first, so symptoms typically begin in the feet.

Symptoms can include:

  • tingling or pins and needles;
  • burning or stabbing pain;
  • numbness or reduced sensation;
  • pain caused by light touch;
  • symptoms that worsen at night;
  • balance problems; and
  • reduced awareness of injuries to the feet.

Loss of sensation can be particularly important because cuts, blisters and pressure injuries may go unnoticed.

Without appropriate foot care, that can increase the risk of ulcers, infections and more serious complications.

Other Forms of Diabetic Neuropathy

Diabetes can also affect other nerves.

Examples include:

  • autonomic neuropathy, affecting functions such as digestion, heart rate, blood pressure, sweating, bladder function and sexual function;
  • proximal neuropathy, which may cause pain and weakness around the hips, thighs or buttocks; and
  • focal or mononeuropathy, involving an individual nerve.

Why Does Diabetic Neuropathy Develop?

Diabetic neuropathy is complex and does not arise from one single mechanism.

Factors can include:

  • long-term metabolic effects of diabetes;
  • elevated glucose exposure;
  • damage to small blood vessels supplying nerves;
  • oxidative stress;
  • inflammation;
  • obesity;
  • abnormal blood lipids; and
  • high blood pressure.

Glucose management remains an important part of prevention and slowing progression, but it is not the only factor.

The 2026 American Diabetes Association recommends optimising glucose management to prevent or delay neuropathy in people with type 1 diabetes and to slow progression in people with type 2 diabetes.

It also recommends optimising weight, blood pressure and lipid management to reduce neuropathy risk or progression.

Importantly, glucose management does not generally restore neurons that have already been lost.

The Uncomfortable Truth About “Nerve Repair” Claims

One of the strongest claims in neuropathy marketing is that a cream, tablet or supplement can repair, regenerate, rebuild or restore damaged nerves.

Current clinical guidance is considerably more cautious.

The American Diabetes Association states that specific treatment capable of reversing the underlying nerve damage associated with diabetic neuropathy is currently not available.

That does not mean nothing can help.

It means three different outcomes need to be separated:

  • reducing symptoms;
  • slowing future progression;
  • reversing existing nerve damage.

A treatment may help with the first without accomplishing the third.

This distinction is essential when evaluating creams and supplements.

Creams, Gels and Sprays: What They Claim Versus Reality

Topical neuropathy products are popular because they are easy to apply and can provide a sense of immediate action at the site of discomfort.

Common ingredients include:

  • capsaicin;
  • menthol;
  • camphor;
  • lidocaine;
  • magnesium;
  • essential oils; and
  • various herbal ingredients.

The important question is not simply whether a cream produces a sensation on the skin.

It is whether that effect meaningfully treats neuropathic pain and whether claims about nerve repair are supported.

Capsaicin: The Best-Studied Topical Option

Capsaicin is derived from chilli peppers and is one of the better-studied topical treatments for neuropathic pain.

Rather than repairing nerves, capsaicin acts on pain-signalling pathways.

This can reduce neuropathic pain in some people.

The 2026 ADA Standards note that an 8% capsaicin patch has clinical evidence for painful diabetic neuropathy, and lower-strength capsaicin cream has also been studied.

Capsaicin can cause burning or stinging, particularly when treatment begins.

It is therefore important to distinguish:

reducing pain signals

from:

healing damaged peripheral nerves.

Capsaicin may help with the first. It has not been shown to accomplish the second.

Lidocaine: Local Numbing Rather Than Nerve Repair

Lidocaine acts as a local anaesthetic.

Applied to a painful area, it can temporarily reduce sensation and pain signalling.

This may be helpful when pain is particularly localised.

However, the effect is temporary.

Lidocaine does not treat the underlying diabetic nerve injury or reverse neuropathy progression.

Menthol and Camphor

Menthol and camphor can create cooling or warming sensations.

For some people, these sensory effects temporarily distract from discomfort.

But feeling cool, warm or numb after applying a cream does not demonstrate that damaged nerves have been repaired.

CBD and Essential Oils

CBD creams and essential-oil products are frequently marketed for nerve pain.

Evidence supporting them specifically for diabetic peripheral neuropathy is considerably less established than for treatments such as capsaicin.

Testimonials and individual reports may describe symptom relief, but these should not be confused with evidence that the products repair diabetic nerve damage.

The Bottom Line on Neuropathy Creams

Some topical treatments can be useful for symptom management.

Depending on the product and ingredient, they may:

  • reduce pain signalling;
  • temporarily numb an area;
  • produce cooling or warming sensations; or
  • make discomfort more tolerable.

They should not automatically be expected to:

  • reverse diabetic neuropathy;
  • regenerate damaged nerves;
  • restore lost sensation; or
  • replace appropriate diabetes and medical care.

Tablets and Supplements: Bigger Promises, Bigger Confusion

Oral supplements are frequently marketed as addressing neuropathy “from the inside out”.

That sounds intuitively attractive.

However, oral administration alone does not establish that a product repairs nerves.

A supplement may contain an ingredient associated with antioxidant activity, vitamin replacement, metabolic effects or experimental nerve-health research.

The evidence for each ingredient and dose still needs to be assessed independently.

Alpha-Lipoic Acid: One of the Better-Researched Options

Alpha-lipoic acid, commonly abbreviated to ALA, is unusual among supplements marketed for diabetic neuropathy because there is genuine human clinical research investigating its use.

ALA is involved in cellular energy metabolism and has antioxidant properties.

Research suggests that oral ALA may reduce some symptoms of diabetic peripheral neuropathy, including:

  • burning;
  • tingling;
  • paraesthesia;
  • numbness; and
  • overall neuropathy symptom scores.

A 2026 systematic review and meta-analysis found favourable results across a number of neuropathy outcomes, with benefits particularly evident for symptoms such as paraesthesia, numbness and burning.

Results were particularly interesting around a dosage of 600mg per day.

However, several other outcomes did not significantly improve, including HbA1c and some objective nerve-conduction measures.

This is an important distinction.

The evidence for ALA is more convincing for improvement in some neuropathy symptoms than it is for proving that damaged nerves have structurally regenerated.

Read the 2026 alpha-lipoic acid systematic review and meta-analysis on PubMed.

What About 600mg R-Alpha Lipoic Acid Supplements?

Alpha-lipoic acid is unusual among neuropathy supplements because there is genuine human clinical research examining its use for diabetic peripheral neuropathy, including research involving a 600mg daily dose.

However, consumers should distinguish between evidence for alpha-lipoic acid generally and evidence for a particular retail formulation.

A clinically researched ingredient does not automatically mean that every commercial product containing that ingredient has itself been clinically tested.

We investigated this issue in detail in our Root of Nature R-Alpha Lipoic Acid 600mg review, where we checked whether the commercial product being advertised was actually the formulation used in landmark ALA clinical research.

One of the major long-term ALA trials, NATHAN 1, identified the tested formulation as Thioctacid HR 600mg from MEDA Pharma, rather than Root of Nature.

That does not prove Root of Nature is ineffective.

It demonstrates why consumers should distinguish between research supporting an ingredient and research specifically involving the finished commercial product being sold.

Read our full Root of Nature R-ALA 600mg investigation →

Vitamin B12: Essential When Deficiency Is the Problem

Vitamin B12 is essential for normal neurological function.

A deficiency can itself cause neuropathy.

This is especially relevant because some people taking metformin can develop reduced vitamin B12 levels over time.

When a genuine B12 deficiency is present, identifying and correcting it is important.

But that does not mean taking additional B12 will repair diabetic nerve damage when B12 levels are already adequate.

This is why determining the cause of neuropathy matters.

Acetyl-L-Carnitine

Acetyl-L-carnitine has been investigated in relation to neuropathic symptoms and nerve metabolism.

Some research has reported improvements in pain or other measures, but the evidence is not strong enough to justify claims that commercial acetyl-L-carnitine supplements reliably regenerate diabetic nerves.

Expectations should remain modest.

Magnesium

Magnesium plays important roles in muscle and nerve function.

Correcting a deficiency can be important for general health.

However, magnesium should not be presented as a proven treatment capable of reversing diabetic peripheral neuropathy.

Turmeric and Curcumin

Curcumin has attracted research interest because of its anti-inflammatory and antioxidant effects.

However, there is a substantial difference between laboratory or mechanistic research and evidence showing that a retail turmeric supplement materially improves established diabetic peripheral neuropathy.

Claims of nerve regeneration require stronger evidence than general anti-inflammatory activity.

Berberine

Berberine is sometimes discussed in diabetes and neuropathy supplement marketing.

Its relevance is primarily metabolic rather than as a direct treatment for damaged peripheral nerves.

Better management of diabetes risk factors may help reduce future neuropathy progression, but that should not be confused with repairing existing nerve injury.

You can explore this broader category in our Complete Guide to Diabetes Supplements in Australia.

The Takeaway on Tablets and Supplements

Supplements can have a role in particular circumstances.

They may:

  • correct a deficiency;
  • provide modest symptom improvement;
  • support another aspect of health; or
  • be reasonable adjuncts when discussed with an appropriate healthcare professional.

What consumers should be wary of are broad claims that a supplement can reliably:

  • reverse diabetic neuropathy;
  • regrow peripheral nerves;
  • restore lost sensation;
  • replace diabetes treatment; or
  • produce pharmaceutical-style results without equivalent evidence.

Comparison: Common Neuropathy Claims Versus Evidence

Product or Ingredient Common Marketing Claim Evidence More Realistic Expectation
Capsaicin Treats nerve pain Meaningful evidence for pain relief Can reduce neuropathic pain signals but does not regenerate nerves
Lidocaine Fast relief Limited/localised role Temporary local numbing
Menthol / camphor Soothes nerve pain Primarily sensory effects Temporary cooling or warming sensation
Alpha-lipoic acid Repairs nerves Moderate evidence for some symptom improvement May reduce burning, tingling or numbness in some people
Vitamin B12 Restores nerves Important if deficient Treating deficiency can prevent further neurological injury
Magnesium Repairs neuropathy Insufficient for nerve-repair claims Useful where deficiency or other indications exist
CBD / essential oils Natural nerve repair Limited specific evidence Possible subjective symptom relief for some users
Multi-ingredient herbal blends Reverses neuropathy Varies widely by formula and dose Finished-product evidence needs to be checked individually

What Actually Helps Manage Diabetic Neuropathy?

The most important interventions are often less dramatic than the products being advertised online.

Current clinical guidance focuses on reducing future risk, identifying complications early and treating painful symptoms appropriately.

1. Optimising Glucose Management

Appropriate glucose management remains central to diabetes care.

The benefit differs between diabetes types.

The ADA states that optimal glucose management can effectively prevent or delay diabetic peripheral neuropathy in type 1 diabetes and may modestly slow progression in type 2 diabetes.

Importantly, it does not reverse neuronal loss that has already occurred.

2. Managing Weight, Blood Pressure and Lipids

Neuropathy risk is not determined by glucose alone.

The 2026 ADA guidance also recommends optimising:

  • weight;
  • blood pressure; and
  • lipid management.

These factors can contribute to neuropathy development and progression, particularly in people with type 2 diabetes.

3. Regular Foot Checks

Foot care is one of the most important practical aspects of neuropathy management.

The ADA recommends a comprehensive foot evaluation at least annually for people with diabetes, with more frequent assessment for people at higher risk.

People with reduced sensation should regularly check for:

  • cuts;
  • blisters;
  • redness;
  • pressure areas;
  • cracks;
  • swelling;
  • changes in skin colour; and
  • signs of infection.

Loss of sensation can allow relatively minor injuries to become serious before they are noticed.

4. Physical Activity

Appropriate physical activity can support overall metabolic health, balance, function and mobility.

The ADA notes that systematic reviews suggest exercise may improve several neuropathy outcomes, although the strength of evidence remains limited.

Exercise should be adapted to individual circumstances, particularly where foot wounds, severe sensory loss, balance problems or other complications are present.

5. Look for Other Causes of Neuropathy

Diabetes does not automatically explain every case of numbness, pain or tingling.

Other possible contributors can include:

  • vitamin B12 deficiency;
  • thyroid disease;
  • kidney disease;
  • alcohol-related nerve damage;
  • chemotherapy;
  • some medications;
  • nerve compression;
  • autoimmune conditions; and
  • other neurological disorders.

This is why the ADA describes diabetic neuropathy as a diagnosis of exclusion.

Prescription Treatments for Painful Diabetic Neuropathy

For some people, diabetic neuropathy is not simply an occasional tingling sensation.

Neuropathic pain can interfere with sleep, mobility, mood and quality of life.

When this occurs, medical treatment may be appropriate.

The 2026 American Diabetes Association Standards recommend several medication classes as initial pharmacological treatments for painful diabetic neuropathy:

  • gabapentinoids such as pregabalin or gabapentin;
  • serotonin-norepinephrine reuptake inhibitors such as duloxetine;
  • tricyclic antidepressants; and
  • certain sodium-channel blockers.

These medicines are intended to manage neuropathic pain.

They do not regenerate damaged peripheral nerves.

Treatment choice depends on individual factors including age, other medicines, kidney function, cardiovascular health, side effects, sleep, mood and other medical conditions.

This decision should be made with a doctor or other appropriately qualified healthcare professional.

The current ADA guidance also advises against routine opioid treatment for diabetic neuropathic pain because potential harms generally outweigh benefits.

How Brighton Savoy assesses neuropathy supplements

When reviewing products marketed for neuropathy, we distinguish between evidence for individual ingredients and evidence involving the actual finished commercial formulation.

We also examine:

  • the ingredient dose;
  • clinical research;
  • whether the commercial product itself has been studied;
  • regulatory information;
  • marketing claims;
  • pricing and refund terms; and
  • whether the advertising fairly reflects what the available evidence actually establishes.

This distinction is particularly important in supplement marketing because a product may cite legitimate research on an ingredient without the finished product itself having undergone the same clinical testing.

You can read more about our methodology in Why We Write Independent Reviews of Diabetes Supplements.

Consumer Warning: How to Spot Questionable Neuropathy Claims

Neuropathy can be uncomfortable, frightening and difficult to treat.

That makes people experiencing symptoms especially attractive targets for aggressive marketing.

Be cautious when a product claims to:

  • “cure diabetic neuropathy”;
  • “regrow damaged nerves”;
  • “reverse nerve damage”;
  • “restore normal sensation”;
  • “work better than prescription medication”;
  • provide guaranteed results;
  • produce dramatic benefits within days; or
  • be “clinically proven” without clearly identifying the research.

Also look carefully at whether the clinical study being cited actually investigated:

  • the same ingredient;
  • the same chemical form;
  • the same dose;
  • the same health condition;
  • the same outcome; and
  • the finished product being sold.

Other Neuropathy Products Brighton Savoy Has Reviewed

Our neuropathy and diabetes research includes several individual product investigations.

The Honest Bottom Line: Realistic Hope, Not False Promises

Living with diabetic neuropathy can be frustrating, uncomfortable and, for some people, exhausting.

It is completely understandable to look for something that might reduce burning, tingling, pain or numbness.

Some treatments genuinely can help with symptoms.

Topical capsaicin can reduce neuropathic pain for some people.

Prescription medicines can substantially improve pain and quality of life for some patients.

Alpha-lipoic acid also has meaningful clinical research suggesting it may improve certain symptoms in some people.

But none of these facts should be converted into a claim that diabetic peripheral nerves can reliably be regenerated with a cream or over-the-counter supplement.

The foundations of managing diabetic neuropathy remain:

  • appropriate glucose management;
  • weight management where relevant;
  • blood pressure and lipid management;
  • regular foot checks and professional foot assessment;
  • appropriate physical activity;
  • identifying other possible causes of neuropathy;
  • treating deficiencies when present; and
  • appropriate medical treatment for painful symptoms.

The 2026 American Diabetes Association Standards of Care state that specific treatment capable of reversing the underlying nerve damage of diabetic neuropathy is currently not available.

That does not mean nothing can help. It means symptom relief, slowing future progression and regenerating already damaged nerves are three different claims, and consumers should not allow marketing to blur the distinction.

Frequently Asked Questions

Can diabetic neuropathy be reversed?

Current clinical guidance does not identify a treatment capable of reliably reversing established diabetic nerve damage. Good metabolic and cardiovascular risk management can help prevent or slow progression, while medications and some topical treatments can help manage symptoms.

Do neuropathy creams actually work?

Some topical treatments can reduce pain or produce temporary symptom relief. Capsaicin has meaningful evidence for painful diabetic neuropathy. Lidocaine can provide localised numbing. These effects should not be confused with repairing damaged nerves.

Does alpha-lipoic acid work for diabetic neuropathy?

Alpha-lipoic acid has human clinical research suggesting it may reduce some symptoms of diabetic peripheral neuropathy, particularly burning, tingling, paraesthesia and numbness. Evidence is stronger for symptom improvement than for proving structural nerve regeneration.

Why is 600mg of alpha-lipoic acid commonly mentioned?

600mg daily has been investigated in several clinical studies and is one of the better-studied oral doses for diabetic neuropathy. Higher doses have not necessarily produced proportionately better outcomes and can increase adverse effects.

Was Root of Nature R-ALA used in the major ALA trials?

Not in the NATHAN 1 study. The published NATHAN 1 paper identifies the tested formulation as Thioctacid HR 600mg from MEDA Pharma. This is why evidence for ALA generally should not automatically be treated as clinical proof of every retail ALA supplement.

Can vitamin B12 improve neuropathy?

Vitamin B12 deficiency can cause neuropathy, so identifying and treating a deficiency is important. Taking additional B12 when levels are already adequate should not be assumed to reverse diabetic nerve damage.

What prescription medicines are used for diabetic nerve pain?

Current ADA guidance includes gabapentinoids, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants and certain sodium-channel blockers as initial medication classes for painful diabetic neuropathy. Treatment should be individualised by a healthcare professional.

Why are foot checks so important?

Neuropathy can reduce sensation, meaning cuts, blisters or pressure injuries can go unnoticed. Regular foot inspection and professional assessment can identify problems before they develop into ulcers, infections or other serious complications.

Sources and Further Reading

Related Brighton Savoy Consumer Research

Medical Disclaimer

This article provides general consumer information and is not medical advice, diagnosis or treatment.

Persistent or worsening numbness, burning, tingling, weakness, loss of sensation or foot changes should be medically assessed.

If you have diabetes, neuropathy or another health condition, or take prescription medicines, speak with your doctor, pharmacist, podiatrist or another appropriately qualified healthcare professional before starting supplements or changing treatment.

Do not start, stop or change prescribed medication because of information contained in this article.

Posted in
Table of Contents
    brightonsavoy-logo

    Brighton Savoy is an independent Australian publishing and information platform covering weddings, hospitality, travel and consumer topics. Drawing on more than five decades of experience operating the former Brighton Savoy hotel and wedding venue in Melbourne, we combine first-hand industry knowledge with current research to create practical guides for Australian consumers.

    Scroll to Top